Cargando…
Tocilizumab Controls Paraneoplastic Inflammatory Syndrome but Does Not Suppress Tumor Growth of Angiomatoid Fibrous Histiocytoma
Angiomatoid fibrous histiocytoma (AFH) is a rare soft tissue tumor that rarely metastasizes but lacks effective systemic therapy once it propagates. In some reports, high interleukin-6 (IL-6) production promotes tumor growth by autocrine stimulation and tocilizumab, an IL-6 receptor antagonist, can...
Autores principales: | Sabe, Hideaki, Inoue, Akitomo, Nagata, Shigenori, Imura, Yoshinori, Wakamatsu, Toru, Takenaka, Satoshi, Tamiya, Hironari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225413/ https://www.ncbi.nlm.nih.gov/pubmed/34221525 http://dx.doi.org/10.1155/2021/5532258 |
Ejemplares similares
-
Tocilizumab for the treatment of paraneoplastic inflammatory syndrome associated with angiomatoid fibrous histiocytoma
por: Eberst, Lauriane, et al.
Publicado: (2020) -
Malignant gastrointestinal neuroectodermal tumor with BRAF mutation and a history of malignant melanoma: A case report
por: Yagi, Toshinari, et al.
Publicado: (2021) -
Eribulin Provides a Remarkable Effect in Trabectedin-Resistant Myxoid Liposarcoma
por: Tamiya, Hironari, et al.
Publicado: (2020) -
Aneurysmal ("angiomatoid") fibrous histiocytoma in a child.
por: Kim, C. J., et al.
Publicado: (1989) -
Subcutaneous Angiomatoid Fibrous Histiocytoma Mimicking Metastatic Melanoma
por: Sparreboom, E., et al.
Publicado: (2012)